Arcadis NV (LON:0N6B)
37.02
+0.14 (0.38%)
At close: Dec 5, 2025
Arcadis NV Market Cap
Arcadis NV has a market cap or net worth of 2.78 billion as of December 9, 2025. Its market cap has decreased by -40.41% in one year.
Market Cap
2.78B
Enterprise Value
3.69B
Revenue
4.23B
Ranking
n/a
PE Ratio
13.61
Stock Price
37.02
Market Cap Chart
Since April 1, 1998, Arcadis NV's market cap has increased from 133.46M to 2.78B, an increase of 1,980.93%. That is a compound annual growth rate of 11.58%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 9, 2025 | 2.78B | -36.45% |
| Dec 31, 2024 | 4.37B | 14.61% |
| Dec 29, 2023 | 3.81B | 30.77% |
| Dec 30, 2022 | 2.92B | -7.06% |
| Dec 31, 2021 | 3.14B | 44.02% |
| Dec 31, 2020 | 2.18B | 39.51% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| AstraZeneca | 210.77B |
| HSBC Holdings | 182.10B |
| Shell | 158.55B |
| Unilever | 110.94B |
| Rio Tinto Group | 94.53B |
| British American Tobacco p.l.c. | 93.13B |
| Rolls-Royce Holdings | 90.78B |
| GSK plc | 72.47B |